This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: University of California. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (2009)
- San Francisco, CA (US) (2014 - 2016)
Company Filing History:
Years Active: 2009-2016
Title: Innovations and Contributions of Zachary A Knight
Introduction
Zachary A Knight is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 3 patents, his work focuses on advancing cancer treatment through innovative methodologies.
Latest Patents
Knight's latest patents include groundbreaking inventions such as PI3 kinase antagonists. This invention provides novel PI3-Kinase antagonists with specific formulas and methods of use. Another notable patent is for substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents. This invention presents new compounds that act as antagonists of PI3 kinase, as well as combinations with tyrosine kinase and mTOR.
Career Highlights
Zachary A Knight is affiliated with the University of California, where he conducts his research and development. His work has been instrumental in the exploration of cancer therapies, contributing to the understanding of kinase inhibitors and their potential applications in medicine.
Collaborations
Knight has collaborated with esteemed colleagues such as Kevan M Shokat and Beth Apsel. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the fight against cancer.
Conclusion
Zachary A Knight's contributions to the field of biochemistry and cancer research are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile